Two groups of 10 healthy ambulatory subjects, i.e., a group of 10 persons s30 years of age (mean age, 27.6 years) and a group of 10 persons .65 years of age (mean age, 70 years), were randomized in a single-trial crossover design to receive 1 and 2 g of cefoperazone with a 1-week washout between doses. The elderly subjects had both decreased estimated creatinine clearances and decreased albumin concentrations in serum. Cefoperazone concentrations in serum of elderly persons were significantly higher at each interval from 30 min to 6 h for the 2-g dose. Compared with that in younger persons, the total clearance in elderly subjects was significantly lower for both the 1-and 2-g doses, the renal clearance was significantly lower for the 2-g dose, and the area under the curve was significantly higher for the 2-g dose in the elderly persons. The half-life at i phase was higher in the elderly persons at both the 1-and 2-g doses but not significantly so. Changes in total clearance and area under the curve and higher levels in serum in the elderly persons suggest a longer duration of antimicrobial activity in this age group.
The elderly (persons of >65 years of age) represent a significant and growing portion of the U.S. population, making up 12% of the total population in 1980 and estimated to increase to 17% in the year 2030 (38) . Disproportionate percentages of health care expenditures (25 to 30%) (22) and prescription drugs dispensed (25%) (9) are generated by this segment of the population. In addition, the incidence of adverse reactions to drugs has been clearly demonstrated to be greater in the elderly (18) .
The newer extended-spectrum beta-lactam antimicrobial agents, with their potent antibacterial activity and relative lack of toxicity, are finding increased use as preferred agents for the treatment of elderly patients with infection. Their safety profile appears to be greater than that of the aminoglycosides that have been shown to be associated with increased rates of toxicity in the elderly (27) .
In view of age-associated altered drug absorption and disposition, decreased protein binding, renal clearance, hepatic drug metabolism (30, 33) , and albumin levels (5, 26) , and increased drug-drug interactions, it is possible that the pharmacokinetics of the new beta-lactam agents are altered as well. The pharmacokinetic properties of ceftriaxone (25) , ceftazidime (23) , and cefotaxime (20) in the elderly have shown differences compared with those in younger subjects.
The pharmacokinetic properties of cefoperazone, a broadspectrum antipseudomonal cephalosporin (19) , have been studied in healthy young volunteers. Excretion is via dual pathways; 15 to 37% is excreted in urine, with the remainder excreted by nonrenal mechanisms, predominantly the hepatobiliary system (12, 17, 36) . Additional studies have been done in patients with impaired renal and hepatic functions (2, 7, 8, 17) and in patients with renal dysfunction and active infection (32) ; altered pharmacokinetic parameters have been noted in these studies. We report here the pharma-cokinetics of cefoperazone in healthy elderly subjects compared with those in younger controls.
MATERIALS AND METHODS
Study subjects. Twenty healthy adult subjects 24 to 78 years of age were divided into two groups. Group Y included five males and five females 24 to 30 years old, and group 0 included eight males and two females 65 to 78 years old. The study protocol was approved by The Mount Sinai School of Medicine Institutional Review Board, and written informed consent was obtained from each volunteer. Exclusion criteria included a history of penicillin or cephalosporin allergy, severe cardiovascular disease, or blood dyscrasia. Prestudy physical examinations, blood cell count, urinalysis, and blood chemistries, including liver function tests, were normal for all subjects.
Clinical parameters. Ideal body weight was estimated by the following formulas: 45.5 + 2.3 kg for every inch (2.54 cm) over 5 feet (1.524 m) for females and 50 + 2.3 kg for every inch over 5 feet for males (14) . Body surface area was determined from a table derived from the method of Sendroy and Cecchini (1, 34) . Creatinine clearance (CLCR) was estimated from the formula of Cockcroft and Gault (10) and normalized to 1.73 m2 of body surface area.
Study design. Single cefoperazone doses of 1 and 2 g were given using a single-blind, randomized, crossover design with a minimum 1-week interval between doses. Cefoperazone was reconstituted in sterile saline and infused intravenously in 50 ml of 5% glucose in water via Soluset for 30 (4) . The mobile phase consisted of 76% 0.1 M P04 buffer (pH 6.0) and 24% acetonitrile. The flow rate was 2.7 ml/min, and the retention time of cefoperazone was 2.5 min. The recovery of cefoperazone was 99%, and the correlation coefficient of the standard curve was 0.999 (4) .
Pharmacokinetic analysis. Curves of cefoperazone concentration in plasma versus time for each of the subjects were described by a two-compartment model with constant-rate input. The best coefficient of determination, r2, from initial JANA stripping of data was used to determine the compartmental analysis (15) . Two-compartmental analysis was done by using PCNONLIN (37 
RESULTS
Clinical data for the 20 subjects are listed in Table 1 . Serum albumin and CLCR were reduced in group 0. Elderly subjects weighed more (P < 0.01) than the young and had higher creatinine levels in serum (P < 0.05). Table 2 gives the mean concentrations of cefoperazone in serum following intravenous administration of 1-and 2-g doses. The mean serum concentration-versus-time profiles following 1-and 2-g doses of cefoperazone administered intravenously are shown in Fig. 1 and 2 . At the 2-g dose, the concentrations in serum from 30 min to 6 h were significantly higher at each interval for the elderly than for the young (P < 0.05).
Clearance of cefoperazone was lower in elderly than in young subjects ( reactions, characterized by tachycardia, sweating, and serum albumin may be more pronounced in advanced zziness, in group Y. All symptoms were reversible and illness associated with serious infection in the elderly. A )rt duration. There were no changes in laboratory greater alteration in these pharmacokinetic parameters of after drug administration in either group.
cefoperazone may be expected in elderly patients who are septic or seriously infected. Studies in patients with renal DISCUSSION dysfunction and infection treated with cefoperazone have demonstrated prolongation of half-life, as well as higher lysis of the demographic data revealed significant trough and peak levels in serum, compared with noninfected Lses in CLCR and serum albumin in the elderly com-patients (32) . A potential decrease in hepatic blood flow with the younger population. The decreases in renal associated with septicemia and serious infection may acin were not unexpected since it is known that renal count for the lack of full compensatory excretion of cefoper-)n decreases with age (31). The differences in serum azone via the hepatic pathway in infected patients with in level were slight but significant for these healthy impaired renal function. Such exaggeration of altered kinetatory elderly volunteers.
ics in elderly patients has been demonstrated in studies with pharmacokinetic data derived in our young subjects other beta-lactam antibiotics. Studies with ceftazidime in mparable with those of previous studies in this age acutely ill infected elderly patients (24, 28) demonstrated group (12, 17, 36) . There were significant decreases in the serum and renal clearances in the elderly compared with the young. With the 2-g dose, significant increases in Cmax and AUC were noted in the aged population; the CL and CLR of cefoperazone were decreased. Recently, the influence of changes in serum protein and drug binding and their effects on total and free drug fractions have been considered (16) . Higher free-drug levels have been demonstrated when highly protein-bound antibiotics were studied in elderly compared with younger patients (25) . Cefoperazone is highly protein bound to the extent of 87 to 93% of the concentration in serum (17) . Other compounds that are highly protein bound, such as ceftriaxone, have been studied in the elderly (25) . There is an increased concentration of free drug in the first 4 h of administration in elderly compared with younger subjects. This may be related to a decrease in protein binding that is more pronounced than can be accounted for by decreases in albumin alone (25) . An- (13, 21) . The increased AUC at both dosages and changes in t1/2P in the elderly compared with the young suggest that the duration of antimicrobial activity may be increased in the elderly. It is believed that the AUC is a good indicator of antimicrobial activity in vivo (11) .
A disulfiramlike reaction with alcohol has been described in patients taking a variety of antimicrobial agents; compounds containing the N-methyl thiotetrazole ring are believed to be associated with these reactions (6, 29) . Although all volunteers in this study were warned of the effects of alcohol (i.e., not to have any intake until >72 h after study drug administration), several members of the younger age group admitted to being noncompliant with this recommendation. Alcohol consumption in a hospital setting is not common. At home, however, when drugs with N-methyl thiotetrazole rings are prescribed, patients must be cautioned about abstinence from alcohol.
In summary, our data suggest prolongation of cefoperazone antimicrobial activity due to increased AUC and t1/2 in the elderly. These differences would be expected to be even greater when treating infected elderly patients as reported in studies with other beta-lactam antibiotics (20, 24, 28 
